These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31751778)

  • 1. 3-Bromopyruvate as a potent covalently reversible inhibitor of New Delhi metallo-β-lactamase-1 (NDM-1).
    Kang PW; Su JP; Sun LY; Gao H; Yang KW
    Eur J Pharm Sci; 2020 Jan; 142():105161. PubMed ID: 31751778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ebsulfur as a potent scaffold for inhibition and labelling of New Delhi metallo-β-lactamase-1 in vitro and in vivo.
    Su J; Liu J; Chen C; Zhang Y; Yang K
    Bioorg Chem; 2019 Mar; 84():192-201. PubMed ID: 30502631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aromatic Schiff bases confer inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1).
    Zhai L; Jiang Y; Shi Y; Lv M; Pu YL; Cheng HL; Zhu JY; Yang KW
    Bioorg Chem; 2022 Sep; 126():105910. PubMed ID: 35653899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pterostilbene restores carbapenem susceptibility in New Delhi metallo-β-lactamase-producing isolates by inhibiting the activity of New Delhi metallo-β-lactamases.
    Liu S; Zhang J; Zhou Y; Hu N; Li J; Wang Y; Niu X; Deng X; Wang J
    Br J Pharmacol; 2019 Dec; 176(23):4548-4557. PubMed ID: 31376166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors.
    Li JQ; Sun LY; Jiang Z; Chen C; Gao H; Chigan JZ; Ding HH; Yang KW
    Bioorg Chem; 2021 Feb; 107():104576. PubMed ID: 33383326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1).
    Nagulapalli Venkata KC; Ellebrecht M; Tripathi SK
    Eur J Med Chem; 2021 Dec; 225():113747. PubMed ID: 34391033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroxyphenyl-substituted thiosemicarbazone: A potent scaffold for the development of metallo-β-lactamases inhibitors and antimicrobial.
    Liu L; Xu YS; Chigan JZ; Zhai L; Ding HH; Wu XR; Chen WY; Yang KW
    Bioorg Chem; 2022 Oct; 127():105928. PubMed ID: 35717802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereochemically altered cephalosporins as potent inhibitors of New Delhi metallo-β-lactamases.
    Hu L; Yang H; Yu T; Chen F; Liu R; Xue S; Zhang S; Mao W; Ji C; Wang H; Xie H
    Eur J Med Chem; 2022 Mar; 232():114174. PubMed ID: 35152091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acylhydrazones confer inhibitory efficacy against New Delhi metallo-β-lactamase-1.
    Gao H; Li JQ; Kang PW; Chigan JZ; Wang H; Liu L; Xu YS; Zhai L; Yang KW
    Bioorg Chem; 2021 Sep; 114():105138. PubMed ID: 34229201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design.
    Linciano P; Cendron L; Gianquinto E; Spyrakis F; Tondi D
    ACS Infect Dis; 2019 Jan; 5(1):9-34. PubMed ID: 30421910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of hydroxamate as a promising scaffold dually inhibiting metallo- and serine-β-lactamases.
    Wu XR; Chen WY; Liu L; Yang KW
    Eur J Med Chem; 2024 Feb; 265():116055. PubMed ID: 38134748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential inhibitors designed against NDM-1 type metallo-β-lactamases: an attempt to enhance efficacies of antibiotics against multi-drug-resistant bacteria.
    Khan AU; Ali A; Danishuddin ; Srivastava G; Sharma A
    Sci Rep; 2017 Aug; 7(1):9207. PubMed ID: 28835636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a novel covalent non-β-lactam inhibitor of the metallo-β-lactamase NDM-1.
    Christopeit T; Albert A; Leiros HS
    Bioorg Med Chem; 2016 Jul; 24(13):2947-2953. PubMed ID: 27184103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiosemicarbazones exhibit inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1).
    Ge Y; Kang PW; Li JQ; Gao H; Zhai L; Sun LY; Chen C; Yang KW
    J Antibiot (Tokyo); 2021 Sep; 74(9):574-579. PubMed ID: 34234284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent research and development of NDM-1 inhibitors.
    Wang T; Xu K; Zhao L; Tong R; Xiong L; Shi J
    Eur J Med Chem; 2021 Nov; 223():113667. PubMed ID: 34225181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The assemblage of covalent and metal binding dual functional scaffold for cross-class metallo-β-lactamases inhibition.
    Chen C; Liu Y; Zhang YJ; Ge Y; Lei JE; Yang KW
    Future Med Chem; 2019 Sep; 11(18):2381-2394. PubMed ID: 31544522
    [No Abstract]   [Full Text] [Related]  

  • 17. Discovery of environment-sensitive fluorescent probes for detecting and inhibiting metallo-β-lactamase.
    Chen C; Xiang Y; Yang KW
    Bioorg Chem; 2022 Nov; 128():106048. PubMed ID: 35952448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dithiocarbamate as a Valuable Scaffold for the Inhibition of Metallo-β-Lactmases.
    Ge Y; Xu LW; Liu Y; Sun LY; Gao H; Li JQ; Yang K
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31694268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active-Site Conformational Fluctuations Promote the Enzymatic Activity of NDM-1.
    Zhang H; Ma G; Zhu Y; Zeng L; Ahmad A; Wang C; Pang B; Fang H; Zhao L; Hao Q
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-Time Monitoring of NDM-1 Activity in Live Bacterial Cells by Isothermal Titration Calorimetry: A New Approach To Measure Inhibition of Antibiotic-Resistant Bacteria.
    Zhang YJ; Wang WM; Oelschlaeger P; Chen C; Lei JE; Lv M; Yang KW
    ACS Infect Dis; 2018 Dec; 4(12):1671-1678. PubMed ID: 30383355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.